Allogene Therapeutics Inc [ALLO] is -11.06% lower this YTD. Is it still time to buy?
Allogene Therapeutics Inc [NASDAQ: ALLO] traded at a low on Thursday, posting a -6.09 loss after which it closed the day’ session at $2.86. The results of the trading session contributed to over 2772065 shares changing hands. Over the past one week, the price volatility